Detalles de la búsqueda
1.
Clinical, biological, and outcome features of P2RY8-CRLF2 and CRLF2 over-expression in pediatric B-cell precursor acute lymphoblastic leukemia according to the CCLG-ALL 2008 and 2018 protocol.
Eur J Haematol
; 110(6): 669-679, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36814093
2.
ß-catenin promotes MTX resistance of leukemia cells by down-regulating FPGS expression via NF-κB.
Cancer Cell Int
; 20: 271, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32587478
3.
Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children.
Cancer Cell Int
; 19: 293, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31807115
4.
The prognostic potential of coilin in association with p27 expression in pediatric acute lymphoblastic leukemia for disease relapse.
Cancer Cell Int
; 18: 106, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30065619
5.
MYCN amplification predicts poor prognosis based on interphase fluorescence in situ hybridization analysis of bone marrow cells in bone marrow metastases of neuroblastoma.
Cancer Cell Int
; 17: 43, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28367105
6.
Low CREBBP expression is associated with adverse long-term outcomes in paediatric acute lymphoblastic leukaemia.
Eur J Haematol
; 99(2): 150-159, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28452416
7.
FPGS rs1544105 polymorphism is associated with treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia.
Cancer Cell Int
; 13(1): 107, 2013 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-24168269
8.
Clinical features, early treatment responses, and outcomes of pediatric acute lymphoblastic leukemia in China with or without specific fusion transcripts: a single institutional study of 1,004 patients.
Am J Hematol
; 87(11): 1022-7, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22911440
9.
MYCN amplification plus 1p36 loss of heterozygosity predicts ultra high risk in bone marrow metastatic neuroblastoma.
Cancer Med
; 11(8): 1837-1849, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35137546
10.
Chromosome 10 abnormality predicts prognosis of neuroblastoma patients with bone marrow metastasis.
Ital J Pediatr
; 47(1): 134, 2021 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34108028
11.
Downregulating CREBBP inhibits proliferation and cell cycle progression and induces daunorubicin resistance in leukemia cells.
Mol Med Rep
; 22(4): 2905-2915, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32945392
12.
Chromosome band 11q23 deletion predicts poor prognosis in bone marrow metastatic neuroblastoma patients without MYCN amplification.
Cancer Commun (Lond)
; 39(1): 68, 2019 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31685009
13.
Serum Interleukin-6 Level and the rs1800795 Polymorphism in its Gene Associated with Neuroblastoma Risk in Chinese Children.
Chin Med J (Engl)
; 131(9): 1075-1078, 2018 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29692379
14.
Polymorphisms in methotrexate transporters and their relationship to plasma methotrexate levels, toxicity of high-dose methotrexate, and outcome of pediatric acute lymphoblastic leukemia.
Oncotarget
; 8(23): 37761-37772, 2017 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28525903
15.
Low expressions of ARS2 and CASP8AP2 predict relapse and poor prognosis in pediatric acute lymphoblastic leukemia patients treated on China CCLG-ALL 2008 protocol.
Leuk Res
; 39(2): 115-23, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25530566
16.
[Progress of studies on genetics of childhood acute leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 21(3): 791-5, 2013 Jun.
Artículo
en Zh
| MEDLINE | ID: mdl-23815942
17.
[Suppression of NAMPT expression enhances the sensitivity of K562 cells to imatinib and its relative mechanism].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
; 20(2): 235-41, 2012 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-22541073
Resultados
1 -
17
de 17
1
Próxima >
>>